Clinical research organisation Chiltern International has announced the further expansion of its European team with the appointment of Steffen Magin
The independent clinical research organisation says it is currently enjoying a sustained period of growth and has decided to further enhance its team with the appointment of Dr Magin as senior business development manager.
Steffen Magin - from Darmstadt near Frankfurt - will be based at Chiltern International's German office and brings extensive expertise to his new role, where he will be responsible for further strengthening business development activities in mainland and continental Europe and help the firm continue to gain international recognition.
He spent around six years in clinical development at the major Japanese pharmaceutical company Takeda, before a three year period at Icon as an international project manager then a further three years at clinical research organisation Imform as a business development manager.
Looking ahead, Magin commented: "The successful companies of the future in this industry must remain focussed on sponsors and dedicated to the performance of all projects, large and small on the international stage."
